Jiabei Biologics
Latest round
- Series A
Last raised
- Nov 2021
Total raised
- $16M
Investors
- 3
About Jiabei Biologics
, Ltd, trading as Jiabei Biologics or Shell BioTech, is a biomedical technology developer that focuses on biopharmaceutical technology development and CDMO technical services. The company's R&D team has more than 120 employees. The company's management team comes from CDMO companies such as WuXi AppTec Group and RuiZhi. It has 6 R&D technical service platforms, 4500 square meters R&D center, and 8000 square meters cGMP production base. In 2020 the new laboratory in Zhangjiang Medical Valley was put into operation, and in 2022 the pharmaceutical GMP factory was officially put into operation. The company engages in the development of biopharmaceutical technology. It provides services such as CDMO for biological drugs, analysis and testing of macromolecules, development evaluation of finished drugs, and microbial fermentation platform. Macromolecule analysis and testing services include activity analysis, protein characterization, physical and chemical analysis and stability testing services. The company generates revenue through the sales of its biopharmaceutical drugs.
Who invested in Jiabei Biologics
3 investors across 2 rounds
See all investors in Jiabei Biologics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Jiabei Biologics
Who invested in Jiabei Biologics?
Jiabei Biologics has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Jiabei Biologics raised?
Jiabei Biologics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Jiabei Biologics last raise money?
Jiabei Biologics's most recent round on record is a Series A, in Nov 2021.
What does Jiabei Biologics do?
, Ltd, trading as Jiabei Biologics or Shell BioTech, is a biomedical technology developer that focuses on biopharmaceutical technology development and CDMO technical services.
Where is Jiabei Biologics headquartered?
Jiabei Biologics is headquartered in Shanghai, China.
Which VCs invest in companies like Jiabei Biologics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Jiabei Biologics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Jiabei Biologics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.